市場調查報告書

橘皮組織治療市場 - 成長,趨勢,預測

Cellulite Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 925270
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
橘皮組織治療市場 - 成長,趨勢,預測 Cellulite Treatment Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

全球橘皮組織治療市場在2020年∼2025年間,預計將以7.9%的年複合成長率擴大。由於久坐的生活方式增加,運動不足,肥胖人口的增加等,也提高橘皮組織治療的需求。

本報告提供橘皮組織治療的世界市場調查,市場概要,各類型、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊 。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各手術
    • 微創
    • 非侵入性
    • 局部
  • 各橘皮組織
    • 軟橘皮組織
    • 硬橘皮組織
    • 水腫性橘皮組織
  • 各終端用戶
    • 醫院
    • 美容整形中心
    • 專門皮膚科診所
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Merz Pharma GmbH & Co KGaA
    • Inceler Medikal Co Ltd
    • Candela Corporation
    • Hologic Inc
    • Cutera Inc
    • Nestle SA
    • Tanceuticals LLC
    • Zimmer Aesthetics
    • cymedics GmbH & Co KG
    • Beijing Nubway S&T Co Ltd

第7章 市場機會及未來趨勢

目錄
Product Code: 67795

The cellulite treatment market studied was anticipated to grow with a CAGR of nearly 7.9% during the forecast period. The major factors attributing to the growth of the market are a rise in the sedentary lifestyle, inactivity, and poor dietary habits resulting in cellulite formation and increased obese population. For instance, according to the World Health Organization report, in 2016, about 650 million adults and 41 million children aged under 5 years were obese worldwide which is expected to grow during the forecast period fueling the market. Furthermore, the formation of cellulite affects an individual's psychological, behavioral, and psychiatric characteristics that are more in developed economies drive the market growth in the forecast period.

Key Market Trends

Non-invasive Procedure segment is Expected to Hold the Major Market Share in the Cellulite Treatment Market

The Non-invasive Procedure segment dominated the market in recent years and is expected to do so over the forecast period due to high demand from specialized dermatology clinics and hospitals owing to the preference of the patients and physicians. Next to the non-invasive segment, the topical products segment witnesses the highest growth rate in terms of market revenue share due to their increasing demand owing to their ease of application without physician's assistance and availability of the wide range of products offered for the treatment which drives the growth of the segment.

The energy-based treatment segment is expected to dominate over the forecast time period, owing to the various advancements witnessed in energy-based devices that allow less painful and more secure and efficient medical aesthetic procedures. Most energy-based devices are non-invasive in nature, and are considered to be safer and have a lower risk of therapy with restricted post-procedural downtime as compared to traditional invasive surgical procedures.

Based on cellulite, the soft cellulite segment is expected to witness a significant growth rate over the forecast period as this cellulite can be treated easily compared to the other forms of cellulite.

Based on the end-user, specialized dermatology clinics segment held the largest market share in recent years and are expected to remain dominant in the global market. The dominance can be attributed to the long-term success rates of therapy due to the availability of skilled and certified professionals specific to the target area at these clinics which reduces the risk of complication.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America has been the primary market for cellulite treatment, owing to the rise in the number of obesity cases due to a sedentary lifestyle and an increase in the adoption of advanced technologies in the region. A rise in a shift towards the Non-invasive treatments from surgical procedures has been increased in recent years. For instance, according to the 2018 Plastic Surgery Statistics, 5.8 million reconstructive procedures were recorded worldwide which was decreased past couple years indicating the preference for Non-invasive treatments fueling the market in the region.

Globally, the cellulite treatment market is expected to witness the fastest growth in Asia-Pacific during the forecast period due to the increasing inclination towards technological advancements and R&D activities in China and India. Furthermore, a rise in awareness and preference for MIS techniques and various types of cellulite treatment is expected to fuel cellulite treatment market growth in the forecast period.

Competitive Landscape

The Cellulite Treatment Market is moderately competitive and consists of several major players. In terms of market revenue share, a few of the key players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products. For instance, in March 2017, Hologic Inc, a leader in women's healthcare systems acquired Cynosure, a leading medical aesthetics systems manufacturer and established a strong footprint in the rapidly growing medical aesthetics market and consolidate its market positions across the globe thereby increasing the global market revenue. Some of the companies which are currently dominating the market are Merz Pharma GmbH & Co. KGaA, Cutera Inc, Hologic Inc, Candela Corporation, and Inceler Medikal Co Ltd.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 The Rise in Prevalence of Obesity Cases
    • 4.2.2 I Increased Relucatance towards Surgical Procedures
  • 4.3 Market Restraints
    • 4.3.1 Less Awareness about Cellulite Treatment in Emerging Countries
    • 4.3.2 Adoption of Substituent Traditional and Herbal Massage Therapies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Procedure
    • 5.1.1 Minimally Invasive
    • 5.1.2 Non-Invasive
    • 5.1.3 Topical
  • 5.2 Cellulite
    • 5.2.1 Soft Cellulite
    • 5.2.2 Hard Cellulite
    • 5.2.3 Edematous Cellulite
  • 5.3 End-User
    • 5.3.1 Hospitals
    • 5.3.2 Cosmetic Surgery Centers
    • 5.3.3 Specialized Dermatology Clinics
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Merz Pharma GmbH & Co KGaA
    • 6.1.2 Inceler Medikal Co Ltd
    • 6.1.3 Candela Corporation
    • 6.1.4 Hologic Inc
    • 6.1.5 Cutera Inc
    • 6.1.6 Nestle S A
    • 6.1.7 Tanceuticals LLC
    • 6.1.8 Zimmer Aesthetics
    • 6.1.9 cymedics GmbH & Co KG
    • 6.1.10 Beijing Nubway S&T Co Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS